{
  "docId": "019de077-8566-7247-8a65-bb40d287c138",
  "docSlug": "3a5ef691e659aba2296672e3bbfa035c",
  "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides",
  "authorId": "an2-therapeutics",
  "authorName": "AN2 Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2025-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 36,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The chart shows Log10 CFU counts in lungs for various treatment groups compared to untreated control.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-8566-7247-8a65-bb40d287c138/20",
  "deckHref": "/decks/019de077-8566-7247-8a65-bb40d287c138",
  "deckJsonHref": "/decks/019de077-8566-7247-8a65-bb40d287c138.json",
  "deckAnchorHref": "/decks/019de077-8566-7247-8a65-bb40d287c138#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.44,
        "x": 0.025,
        "y": 0.22
      },
      "kind": "chart",
      "text": "Dot plot showing Lung Log10 CFU for different treatment groups",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "170a6240-97af-470f-9b34-235df90f8de1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.5,
        "x": 0.48,
        "y": 0.22
      },
      "kind": "list",
      "text": "EBO showed cidal activity against multiple isolates (10) in an acute pulmonary murine infection model of melioidosis when subcutaneous (SC) dosing was delayed 12-hours after infection (conducted to date)\nMIC90 of 1 µg/mL against 242 recent clinical isolates from NE Thailand\nEBO plus ceftazidime (CAZ) exhibits improved activity vs EBO or CAZ alone in a macrophage and murine models of infection (PLoS Negl. Trop Dis 17: e0011795)\nEBO has an additive effect to CAZ in macrophages and murine infection models (PLoS Negl. Trop Dis 17: e0011795)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "94f71f59-3f1c-42d0-97e4-fce93dd0d269",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.025,
        "y": 0.83
      },
      "kind": "source-note",
      "text": "PLoS Negl Trop Dis 17: e0011795",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54bd32a9-6651-4d8b-b8b9-2cdf229d9fc8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.025,
        "y": 0.04
      },
      "kind": "title",
      "text": "Potential to Reduce Mortality in Patients vs. SOC Alone",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b208b30a-d14c-4e1b-9e71-154b1059c5ab",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 21,
      "from": 18,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ca1bff99-ab8b-4217-9926-524e39a8b895",
      "evidence": "The document presents the potential benefits of AN2 Therapeutics' pipeline candidates in reducing mortality and improving patient outcomes.",
      "position": 0,
      "objective": "What is the cost of inaction in addressing these diseases?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}